Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
The ECHO93 study is a non-healthcare interventional study. Its aim is to evaluate the effect of introducing the echOpen probe into the management of patients referred to the Jean Verdier UDR, in terms of time to diagnosis.
The study is divided into 3 phases:
Phase 1: opening of the Rapid Diagnosis Unit (UDR) at Jean Verdier Hospital Phase 2: Opening of the Jean Verdier Hospital UDR, MSP Pantin, Dr TAYBALY's medical practice in Aulnay-sous-Bois, one month after the start of phase 1.
Phase 3: Opening of the Jean Verdier Hospital Health Bus, one month after the start of phase 2.
Full description
This research will be carried out in 3 phases:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Adult patient over 18 years of age
Patient with signed informed consent
Patient managed by:
Exclusion criteria
Patient on the UDR iron-deficiency anemia clinical pathway
Patient deprived of liberty by judicial or administrative decision
Patient who does not speak French and cannot benefit from the presence of a relative or translator (physical or online)
Patient with a contraindication to the use of EchOPen:
Primary purpose
Allocation
Interventional model
Masking
100 participants in 1 patient group
Loading...
Central trial contact
Anne BOURGARIT, PUPH; Fadhila MESSANI
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal